Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-14 4:31 pm Purchase | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Schonfeld Strategic Advisors LLC | 770,400 6.14% | 770,400 (New Position) | View |
| 2023-02-13 4:16 pm Unchanged | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Dellora Investments LP | 648,752 5.2% | 0 (Unchanged) | View |
| 2023-02-06 11:27 am Sale | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | SPHERA FUNDS MANAGEMENT LTD. | 250,000 1.99% | -258,322 (-50.82%) | View |
| 2023-01-26 1:36 pm Purchase | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | ACORN BIOVENTURES L.P. | 2,815,146 9.99% | 470,655 (+20.07%) | View |
| 2022-08-22 1:17 pm Purchase | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Dellora Investments LP | 648,752 5.2% | 648,752 (New Position) | View |
| 2022-02-14 4:34 pm Sale | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Ikarian Capital LLC | 99,422 1% | -300,578 (-75.14%) | View |
| 2022-02-14 06:15 am Purchase | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | SPHERA FUNDS MANAGEMENT LTD. | 508,322 5.1% | 1,498 (+0.30%) | View |
| 2022-02-04 4:03 pm Purchase | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Hudson Bay Capital Management LP | 412,500 3.97% | 145,833 (+54.69%) | View |
| 2021-03-18 12:59 pm Purchase | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | SPHERA FUNDS MANAGEMENT LTD. | 506,824 6.29% | 506,824 (New Position) | View |
| 2021-02-16 09:57 am Purchase | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | CVI Investments Inc. | 280,981 4.9% | 1,292 (+0.46%) | View |
| 2021-02-12 4:58 pm Purchase | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | ACORN BIOVENTURES L.P. | 2,344,491 9.99% | 2,344,491 (New Position) | View |
| 2021-02-11 09:41 am Sale | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | RENAISSANCE TECHNOLOGIES LLC | 0 0% | -1,269,326 (Position Closed) | View |
| 2021-02-09 2:28 pm Sale | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Hudson Bay Capital Management LP | 412,500 7.16% | -1,619,055 (-79.70%) | View |
| 2021-01-08 9:59 pm Purchase | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Ikarian Capital LLC | 400,000 8.2% | 400,000 (New Position) | View |
| 2020-12-28 3:02 pm Purchase | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | PURA VIDA INVESTMENTS LLC | 475,000 8.88% | 475,000 (New Position) | View |
| 2020-12-23 4:42 pm Purchase | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Aspire Capital Fund LLC | 270,000 5.05% | 270,000 (New Position) | View |
| 2020-05-05 5:23 pm Sale | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Eastern Capital LTD | 108,363 3.9% | -2,058,898 (-95.00%) | View |
| 2020-04-30 11:35 am Purchase | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | CVI Investments Inc. | 279,689 9.9% | 279,689 (New Position) | View |
| 2020-02-12 12:20 pm Purchase | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | RENAISSANCE TECHNOLOGIES LLC | 1,269,326 7.38% | 1,269,326 (New Position) | View |